Delving Into Borderline Personality Disorder Clinical Trial Experiences
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Power Life Sciences Inc.
- Study ID
- NCT05989529
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Borderline Personality Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Taking part in medical study usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical research experience of borderline personality disorder patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future borderline personality disorder patients.
Key Dates
- Start date
- Sep 30, 2024
- Status verified
- Aug 2023
- Primary completion
- Sep 30, 2025
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Number of patients who decide to enroll in a borderline personality disorder clinical research [ Time Frame: 3 months ]
Central Contacts
- Michael B Gill415-900-4227
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Power Life Sciences | San Francisco | California | 94107 |
Find similar trials in San Francisco, CA
Related Studies
- Treatment of Borderline Personality Disorder With rTMSRecruiting · University of California, Los Angeles · Los Angeles, California
- Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel TherapeuticsRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric PopulationsRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- A Precision Medicine Approach to Target Engagement for Emotion RegulationRecruiting · Matthew Southward, PhD · Columbus, Ohio